$CEAD
CEA Industries Inc. Stock $cead

$cead Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017264 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$1.064M	$4.683M	$1.744M
YoY Change	-64.72%	168.43%	-26.29%
Cost Of Revenue	$985.0K	$3.829M	$1.654M
YoY Change	-63.63%	131.53%	-18.2%
Gross Profit	$78.69K	$853.3K	$90.51K
YoY Change	-74.3%	842.74%	-73.74%
Gross Profit Margin	7.4%	18.22%	5.19%
Selling, General & Admin	$750.2K	$1.021M	$1.563M
YoY Change	-30.55%	-34.69%	70.31%
% of Gross Profit	953.27%	119.62%	1726.65%
Research & Development	$74.00	$76.41K	$138.9K
YoY Change	-99.87%	-44.99%	23.33%
% of Gross Profit	0.09%	8.96%	153.49%
Depreciation & Amortization	$7.490K	$7.500K	$8.560K
YoY Change	-7.99%	-12.38%	-53.43%
% of Gross Profit	9.52%	0.88%	9.46%
Operating Expenses	$783.3K	$1.299M	$1.702M
YoY Change	-62.29%	-23.64%	65.17%
Operating Profit	-$704.6K	-$446.2K	-$1.611M
YoY Change	-60.22%	-72.31%	134.99%
Interest Expense	$8.980K	$9.020K	$3.260K
YoY Change	-15.28%	176.69%	-552.78%
% of Operating Profit
Other Income/Expense, Net	$11.05K	$14.72K	$185.0K
YoY Change	4.27%	-92.04%
Pretax Income	-$693.6K	-$431.4K	-$1.423M
YoY Change	-60.61%	-69.68%	79.35%
Income Tax
% Of Pretax Income
Net Earnings	-$693.6K	-$431.4K	-$1.423M
YoY Change	-60.61%	-69.68%	79.35%
Net Earnings / Revenue	-65.2%	-9.21%	-81.57%
Basic Earnings Per Share	-$0.09	-$0.05	-$0.41
Diluted Earnings Per Share	-$0.09	-$0.05	-$307.8K
COMMON SHARES
Basic Shares Outstanding	8.076M shares	8.076M shares	4.622M shares
Diluted Shares Outstanding	8.076M shares	8.072M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.20M	$15.95M	$22.03M
YoY Change	-31.12%	-27.62%	573.58%
Cash & Equivalents	$14.20M	$15.95M	$22.03M
Short-Term Investments
Other Short-Term Assets	$520.3K	$471.1K	$1.774M
YoY Change	-81.98%	-73.45%	-14.06%
Inventory	$397.2K	$441.1K	$1.006M
Prepaid Expenses
Receivables	$293.8K	$61.77K	$191.0K
Other Receivables	$0.00	$0.00	$50.76K
Total Short-Term Assets	$15.41M	$16.92M	$25.06M
YoY Change	-36.12%	-32.46%	326.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$53.23K	$60.71K	$617.7K
YoY Change	-37.15%	-90.17%	41.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$14.75K	$14.75K	$14.75K
YoY Change	0.0%	0.0%	83.0%
Total Long-Term Assets	$479.8K	$513.8K	$1.265M
YoY Change	-22.12%	-59.39%	16.84%
TOTAL ASSETS
Total Short-Term Assets	$15.41M	$16.92M	$25.06M
Total Long-Term Assets	$479.8K	$513.8K	$1.265M
Total Assets	$15.89M	$17.44M	$26.32M
YoY Change	-35.77%	-33.76%	277.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$280.8K	$714.6K	$729.0K
YoY Change	35.22%	-1.98%	-15.24%
Accrued Expenses	$640.1K	$569.8K	$855.7K
YoY Change	-35.81%	-33.41%	-31.36%
Deferred Revenue	$625.9K	$1.103M
YoY Change	-89.45%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.547M	$2.387M	$7.107M
YoY Change	-78.45%	-66.41%	-13.65%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$319.3K	$348.2K	$459.5K
YoY Change	-26.18%	-24.22%	219.15%
Total Long-Term Liabilities	$319.2K	$348.2K	$459.5K
YoY Change	-26.18%	-24.22%	-30.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.547M	$2.387M	$7.107M
Total Long-Term Liabilities	$319.2K	$348.2K	$459.5K
Total Liabilities	$1.866M	$2.735M	$7.567M
YoY Change	-75.48%	-63.85%	-14.88%
SHAREHOLDERS EQUITY
Retained Earnings	-$35.40M	-$34.71M
YoY Change	10.76%
Common Stock	$81.00	$81.00
YoY Change	1.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$14.02M	$14.70M	$18.75M
YoY Change
Total Liabilities & Shareholders Equity	$15.89M	$17.44M	$26.32M
YoY Change	-35.77%	-33.76%	277.93%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$693.6K	-$431.4K	-$1.423M
YoY Change	-60.61%	-69.68%	79.35%
Depreciation, Depletion And Amortization	$7.490K	$7.500K	$8.560K
YoY Change	-7.99%	-12.38%	-53.43%
Cash From Operating Activities	-$1.751M	-$2.689M	$192.9K
YoY Change	22.89%	-1494.4%	-60.18%
INVESTING ACTIVITIES
Capital Expenditures	$0.00		-$13.95K
YoY Change			13.14%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$200.00
YoY Change	-100.0%
Cash From Investing Activities	$0.00	$200.00	-$13.95K
YoY Change	-100.0%	-101.43%	13.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$22.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000		19.70M
YoY Change			3730.25%
NET CHANGE
Cash From Operating Activities	-1.751M	-$2.689M	192.9K
Cash From Investing Activities	0.000	$200.00	-13.95K
Cash From Financing Activities	0.000		19.70M
Net Change In Cash	-1.751M	-$2.689M	19.87M
YoY Change	23.08%	-113.53%	1915.13%
FREE CASH FLOW
Cash From Operating Activities	-$1.751M	-$2.689M	$192.9K
Capital Expenditures	$0.00		-$13.95K
Free Cash Flow	-$1.751M	-$2.689M	$206.8K
YoY Change	22.89%	-1400.34%	-58.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001482541
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	CEAD	Convertible Preferred Stock Converted To Securities ConvertiblePreferredStockConvertedToSecurities		usd
CY2023Q1	CEAD	Deemed Dividend Preferred Stock On Down Round DeemedDividendPreferredStockOnDownRound		usd
CY2023Q1	CEAD	Stock Issued During Period Value Common Shares Issued In Settlement Of Restricted Stock Units Issued To Directors StockIssuedDuringPeriodValueCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors		usd
CY2022Q1	CEAD	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2023Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock		usd
CY2023Q1	CEAD	Payments For Redemption Of Preferred Stock PaymentsForRedemptionOfPreferredStock		usd
CY2023Q1	CEAD	Cash Proceeds From Sale Of Common Stock And Warrants Net Of Issuance Costs CashProceedsFromSaleOfCommonStockAndWarrantsNetOfIssuanceCosts		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	CEAD	Noncash Investing And Financing Activities Conversion Of Series B Preferred Stock NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock		usd
CY2023Q1	CEAD	Noncash Investing And Financing Activities Deemed Dividend Preferred Stock Arising On Down Round NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound		usd
CY2022Q1	CEAD	Options Issued For Accrued Equity Compensation Liability OptionsIssuedForAccruedEquityCompensationLiability		usd
CY2022Q4	CEAD	Class Of Warrant Or Right Outstanding Aggregate Intrinsic Value ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2023Q1	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted		shares
CY2023Q1	CEAD	Class Of Warrant Or Right Weighted Average Exercise Price Granted ClassOfWarrantOrRightWeightedAverageExercisePriceGranted
CY2023Q1	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Granted Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms
CY2023Q1	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Granted SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted		usd
CY2023Q1	CEAD	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised		shares
CY2023Q1	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised		shares
CY2023Q1	CEAD	Class Of Warrant Or Right Weighted Average Exercise Price Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceExercised
CY2023Q1	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercised Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms
CY2023Q1	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Exercised SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
CY2023Q1	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations		shares
CY2023Q1	CEAD	Class Of Warrant Or Right Weighted Average Exercise Price Expired ClassOfWarrantOrRightWeightedAverageExercisePriceExpired
CY2023Q1	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Expirations SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations		usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-41266
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	CEA INDUSTRIES INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-3911608
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	385 South Pierce Avenue
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite C
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Louisville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80027
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80027
CY2023Q1	dei	City Area Code CityAreaCode	(303)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	993-5271
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8076372	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15948077	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18637114	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	61774	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2649	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	441133	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	348411	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	471137	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1489921	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	16922121	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	20478095	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60713	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	68513	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1830	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1830	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14747	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14747	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	436549	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	462874	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	513839	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	547964	usd
CY2023Q1	us-gaap	Assets Assets	17435960	usd
CY2022Q4	us-gaap	Assets Assets	21026059	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1164134	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1207258	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1102601	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4338570	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	89970	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	120245	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	118235	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2386980	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5754033	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	348179	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	376851	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	348179	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	376851	usd
CY2023Q1	us-gaap	Liabilities Liabilities	2735159	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6130884	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8076372	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8076372	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7953974	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7953974	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	81	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	80	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49410899	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49173836	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34710179	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34278741	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	14700801	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14895175	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17435960	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21026059	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4682573	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1744427	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	3829297	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	1653919	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	853276	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	90508	usd
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	202323	usd
CY2022Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	251015	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	76413	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	138918	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1020702	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1311777	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1299438	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1701710	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-446162	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1611202	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5704	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	185000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	9020	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	3260	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14724	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	188260	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-431438	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1422942	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-431438	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1422942	usd
CY2022Q1	CEAD	Convertible Preferred Stock Converted To Securities ConvertiblePreferredStockConvertedToSecurities	35984	usd
CY2022Q1	CEAD	Deemed Dividend Preferred Stock On Down Round DeemedDividendPreferredStockOnDownRound	439999	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-431438	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-43124	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	43438	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-3235970	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2645579	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-26662	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-14811	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1898925	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8071731	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4622427	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14895175	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14895175	usd
CY2023Q1	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Employees AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees	135748	usd
CY2023Q1	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Restricted Stock Units Issued To Directors AdjustmentsToAdditionalPaidInCapitalFairValueOfRestrictedStockUnitsIssuedToDirectors	101316	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-431438	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	14700801	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	14700801	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3570533	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3570533	usd
CY2022Q1	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Employees AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees	32938	usd
CY2022Q1	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Directors AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToDirectors	29656	usd
CY2022Q1	CEAD	Stock Issued During Period Value Common Shares Issued In Settlement Of Restricted Stock Units Issued To Directors StockIssuedDuringPeriodValueCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors	24994	usd
CY2022Q1	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Restricted Stock Units Issued To Directors AdjustmentsToAdditionalPaidInCapitalFairValueOfRestrictedStockUnitsIssuedToDirectors	4928	usd
CY2022Q1	CEAD	Common Shares And Warrants Issued Value For Cash CommonSharesAndWarrantsIssuedValueForCash	21711131	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1980000	usd
CY2022Q1	CEAD	Adjustments To Additional Paid In Capital Dividends On Preferred Stock AdjustmentsToAdditionalPaidInCapitalDividendsOnPreferredStock	-35984	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1422942	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	18754188	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	18754188	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-431438	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1422942	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7500	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8556	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	147094	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	92517	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1705	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-22168	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	33638	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	3676	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-100	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-5499	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	26325	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	25433	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	57420	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10610	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	126360	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	631269	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-1018785	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	551261	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2689237	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	192857	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13948	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	200	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	200	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13948	usd
CY2022Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	35984	usd
CY2022Q1	CEAD	Payments For Redemption Of Preferred Stock PaymentsForRedemptionOfPreferredStock	1980000	usd
CY2022Q1	CEAD	Cash Proceeds From Sale Of Common Stock And Warrants Net Of Issuance Costs CashProceedsFromSaleOfCommonStockAndWarrantsNetOfIssuanceCosts	21711131	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19695147	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2689037	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19874056	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18637114	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2159608	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15948077	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22033664	usd
CY2022Q1	CEAD	Noncash Investing And Financing Activities Conversion Of Series B Preferred Stock NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock	1980000	usd
CY2022Q1	CEAD	Noncash Investing And Financing Activities Deemed Dividend Preferred Stock Arising On Down Round NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound	439999	usd
CY2023Q1	CEAD	Options Issued For Accrued Equity Compensation Liability OptionsIssuedForAccruedEquityCompensationLiability	89970	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zvAhFusiLu2h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zR7Zo7876yeb">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Cash Cash	15948000	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	15698000	usd
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	8010957	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	8021057	shares
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	631064	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4682573	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1744427	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1102601	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4338570	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3852906	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1162374	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1869000	usd
CY2023Q1	CEAD	Remaining Performance Obligations Related To Engineering Only Paid Contracts RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts	172000	usd
CY2023Q1	CEAD	Remaining Performance Obligations Related To Partial Equipment Paid Contracts RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts	1697000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1869000	usd
CY2023Q1	us-gaap	Standard Product Warranty Description StandardProductWarrantyDescription	The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue.
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	188738	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	180457	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.5223	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0348	pure
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	147094	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	92517	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_z1eesnxzi9D4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zNovU5IlTtrb">Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zNYdvRSY4pqk" title="Concentration risk percentage">39</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zp4xGlsN5APh" title="Concentration risk percentage">28</span>%, and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zt1dR6zKjLh1" title="Concentration risk percentage">17</span>% of the Company’s revenue for the three months ended March 31, 2023. One customer accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zPS2PeSFYeYa" title="Concentration risk percentage">35</span>% of the Company’s revenue for the three months ended March 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zjdyYv4Rz5g3" title="Concentration risk percentage">68</span>%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zQ3SBRtMBjml" title="Concentration risk percentage">20</span>%, and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zsbss9HRwcKd" title="Concentration risk percentage">10</span>% of the Company’s accounts receivable as of March 31, 2023. Two customers accounted for<span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zSsuZ45BhDWg" title="Concentration risk percentage"> 57</span>% and<span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zCqHsSuMSjRl" title="Concentration risk percentage"> 43</span>% of the Company’s accounts receivable as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	436549	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	120245	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	348179	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M18D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0363	pure
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	31069	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	124897	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	128643	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	132503	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	136473	usd
CY2023Q1	CEAD	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	11654	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	534170	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	65746	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	468424	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	410208	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	270555	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	154	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	155	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	135316	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	148608	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	104545	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	70907	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	441133	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	348411	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	14101	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	12770	usd
CY2023Q1	CEAD	Prepaid Inventory Expenses PrepaidInventoryExpenses	219000	usd
CY2022Q4	CEAD	Prepaid Inventory Expenses PrepaidInventoryExpenses	1176000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	290994	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	293389	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	230281	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	224876	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60713	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	68513	usd
CY2023Q1	us-gaap	Depreciation Depreciation	7500	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	714586	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	311162	usd
CY2023Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	24468	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	25951	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	167697	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	465094	usd
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	188738	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	180457	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	68645	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	224594	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1164134	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1207258	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8076372	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8076372	shares
CY2022Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	one-for-one hundred and fifty
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Splits StockIssuedDuringPeriodSharesStockSplits	6798	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	240125224	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	240125224	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1600835	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1600835	shares
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	22000000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	169530	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	170382	shares
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	89970	usd
CY2023Q1	CEAD	Employee Stock Ownership Plan Additional Expense EmployeeStockOwnershipPlanAdditionalExpense	32376	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	7623772	shares
CY2022Q4	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	7623772	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.14
CY2023Q1	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms	P49M
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	7623772	shares
CY2023Q1	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	7623772	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.14
CY2023Q1	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm	P46M
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	7623772	shares
CY2023Q1	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	7623772	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P46M
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	26380000	usd
CY2023Q1	CEAD	Net Operating Loss Carry Forward Expected To Expire Amount NetOperatingLossCarryForwardExpectedToExpireAmount	11196000	usd
CY2023Q1	CEAD	Net Operating Loss Expiration Term NetOperatingLossExpirationTerm	2034 through 2037
CY2023Q1	CEAD	Nols Usage Against Taxable Income Percentage NolsUsageAgainstTaxableIncomePercentage	0.80	pure
CY2023Q1	CEAD	Nols Carryforwards Term Description NolsCarryforwardsTermDescription	three-year period
CY2023Q1	us-gaap	Payments For Commissions PaymentsForCommissions	18273	usd
CY2022Q1	us-gaap	Payments For Commissions PaymentsForCommissions	7555	usd
CY2023Q1	us-gaap	Payments For Deposits PaymentsForDeposits	14035	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16977	usd

Files In Submission

Name	View Source	Status
cead-20230331_def.xml	Edgar Link	unprocessable
cead-20230331_cal.xml	Edgar Link	unprocessable
0001493152-23-017264-index-headers.html	Edgar Link	pending
0001493152-23-017264-index.html	Edgar Link	pending
0001493152-23-017264.txt	Edgar Link	pending
0001493152-23-017264-xbrl.zip	Edgar Link	pending
cead-20230331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
cead-20230331_lab.xml	Edgar Link	unprocessable
cead-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CEAD
CEA Industries Inc. Stock $cead

2023 Q2 Form 10-Q Financial Statement

#000149315223017264 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CEAD CEA Industries Inc. Stock $cead

2023 Q2 Form 10-Q Financial Statement

#000149315223017264 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CEAD
CEA Industries Inc. Stock $cead